Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

Abstract

Among body composition parameters, only MA has robust prognostic impact for OS. Data suggest that treatment approaches targeting muscle quality are unlikely to prolong OS noticeably on their own in advanced gastric cancer patients, indicating that multimodal approaches should be pursued in the future.